YTHDF1 and hepatocellular carcinoma: Furthermore, METTL3 and YTHDF1 overexpression in HCC cells were required for the BM process, thus highlighting METTL3 and YTHDF1 as potential predictive biomarkers and therapeutic targets for HCC.